Is it true that the targeted drug giritinib is given away?

Gilteritinib has significant efficacy in the treatment of patients with relapsed or refractory acute myeloid leukemia. Studies have shown that the drug can effectively improve patients' progression-free survival and overall survival. In addition, giritinib can also reduce the disease burden before bone marrow transplantation and provide better therapeutic effects for patients receiving stem cell transplantation.

Drug donation policies are usually provided by pharmaceutical companies, charities or hospitals to patients who meet certain conditions. These conditions may involve income level, need for treatment and other factors. If you are interested in the drug donation policy of giritinib, it is recommended to contact the pharmaceutical company or medical institution directly to inquire whether there is a drug donation program or drug assistance program applicable to patients. Relevant information can currently be obtained through their official website, customer service hotline, or by communicating with a doctor. Also, consider contacting a professional charity or non-profit organization to see if there are programs that provide medication gifts to eligible patients.

The original drug of giritinib has been launched in China, but it has not yet been included in the medical insurance. The price of each box of 40mg*42 tablets may be more than 20,000 yuan, and the price of the Hong Kong version of the original drug is about 90,000 yuan per box. The price of the European version of the original drug, 40mg*84 tablets, per box listed overseas is around RMB 210,000 (the price may fluctuate due to exchange rates), which is very expensive. Generic drugs of giritinib are currently produced and sold overseas, and their drug ingredients are basically the same as those of the original drugs sold domestically and abroad. For example, the price of 40mg*84 tablets per box produced by a Laos pharmaceutical factory is more than 4,000 yuan (the price may fluctuate due to the exchange rate).